These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 23008174

  • 1. Huntington's disease: how intermediate are intermediate repeat lengths?
    Squitieri F, Jankovic J.
    Mov Disord; 2012 Dec; 27(14):1714-7. PubMed ID: 23008174
    [Abstract] [Full Text] [Related]

  • 2. Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.
    Savitt D, Jankovic J.
    J Neurol Sci; 2019 Jul 15; 402():57-61. PubMed ID: 31103960
    [Abstract] [Full Text] [Related]

  • 3. Is There Convincing Evidence that Intermediate Repeats in the HTT Gene Cause Huntington's Disease?
    Oosterloo M, Van Belzen MJ, Bijlsma EK, Roos RA.
    J Huntingtons Dis; 2015 Jul 15; 4(2):141-8. PubMed ID: 26397895
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HD CAGnome: a search tool for huntingtin CAG repeat length-correlated genes.
    Galkina EI, Shin A, Coser KR, Shioda T, Kohane IS, Seong IS, Wheeler VC, Gusella JF, Macdonald ME, Lee JM.
    PLoS One; 2014 Jul 15; 9(4):e95556. PubMed ID: 24751919
    [Abstract] [Full Text] [Related]

  • 9. HTT gene intermediate alleles in neurodegeneration: evidence for association with Alzheimer's disease.
    Menéndez-González M, Clarimón J, Rosas-Allende I, Blázquez M, San Martín ES, García-Fernández C, Lleó A, Dols-Icardo O, Illán-Gala I, Morís G, Ribacoba R, Álvarez V, Martínez C.
    Neurobiol Aging; 2019 Apr 15; 76():215.e9-215.e14. PubMed ID: 30583877
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease.
    Aldous SG, Smith EJ, Landles C, Osborne GF, Cañibano-Pico M, Nita IM, Phillips J, Zhang Y, Jin B, Hirst MB, Benn CL, Bond BC, Edelmann W, Greene JR, Bates GP.
    Brain; 2024 May 03; 147(5):1784-1798. PubMed ID: 38387080
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS.
    Killoran A, Biglan KM, Jankovic J, Eberly S, Kayson E, Oakes D, Young AB, Shoulson I.
    Neurology; 2013 May 28; 80(22):2022-7. PubMed ID: 23624566
    [Abstract] [Full Text] [Related]

  • 13. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Kenney C, Powell S, Jankovic J.
    Mov Disord; 2007 Jan 28; 22(1):127-30. PubMed ID: 17115386
    [Abstract] [Full Text] [Related]

  • 14. Analysis of HTT CAG repeat expansion among healthy individuals and patients with chorea in Korea.
    Kim R, Seong MW, Oh B, Shin HS, Lee JS, Park S, Jang M, Jeon B, Kim HJ, Lee JY.
    Parkinsonism Relat Disord; 2024 Jan 28; 118():105930. PubMed ID: 37992538
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical and Molecular Findings of Intermediate Allele Carriers in the HTT Gene from the Mexican Mestizo Population.
    Ramírez-García MÁ, Dávila-Ortiz de Montellano DJ, Martínez-Ruano L, Ochoa-Morales A, Romero-Hidalgo S, Zenteno JC, Yescas-Gómez P.
    Neurodegener Dis; 2022 Jan 28; 22(1):34-42. PubMed ID: 35926480
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.